Loniten and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Loniten (minoxidil), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Plavix, and have Anaemia.

The phase IV clinical study analyzes which people have Weakness when taking Loniten. It is created by eHealthMe based on reports of 354 people who have side effects when taking Loniten from the FDA, and is updated regularly.

What is Loniten?

Loniten has active ingredients of minoxidil. eHealthMe is studying from 363 Loniten users. Check the latest studies of Loniten.

What is Weakness?

Weakness is found to be associated with 3,640 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 20, 2026

354 people reported to have side effects when taking Loniten.
Among them, 20 people (5.65%) have Weakness.

Among these 20 people:

How long have people been on Loniten when they have Weakness? *

What is the gender of people who have Weakness when taking Loniten? *

female: 70 %
male: 30 %

What is the age of people who have Weakness when taking Loniten? *

What are other drugs people take besides Loniten? *

What are other side effects people have besides Weakness? *

Oedema Peripheral (superficial swelling): 11 people, 55.00%
Pain: 10 people, 50.00%
Dry Skin: 8 people, 40.00%
Stress And Anxiety: 8 people, 40.00%
Emotional Distress: 7 people, 35.00%
Skin Exfoliation (removal of the oldest dead skin cells): 7 people, 35.00%
Chest Pain: 7 people, 35.00%
Joint Stiffness: 6 people, 30.00%
Skin Hypertrophy (skin cells enlarges): 6 people, 30.00%
Rash Macular (small, flat red spots): 6 people, 30.00%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 6 people, 30.00%
Diabetes: 6 people, 30.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 30.00%
Anaemia (lack of blood): 6 people, 30.00%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 10.00%
Pain: 2 people, 10.00%
High Blood Pressure: 2 people, 10.00%
Hair Loss: 2 people, 10.00%
Type 2 Diabetes: 1 person, 5.00%
Renal Cancer Metastatic (cancer of kidney spreads to other part): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Loniten and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Loniten:

Loniten (363 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Loniten:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,640 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,612 conditions)

Related publications that referenced our studies

Dubrey SW, VanGriethuysen J, Edwards CM, "A hairy fall: syncope resulting from topical application of minoxidil", BMJ case reports, 2015 Sep .
Dubrey SW, VanGriethuysen J, Edwards CM, "A hairy fall: syncope resulting from topical application of minoxidil", BMJ case reports, 2015 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on minoxidil (the active ingredients of Loniten) and Loniten (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.